By Justin Yamashita, MSc. Benchtop, site, CRO: three levels of basic and clinical research, explained without spin.
From Open Label Media, the team behind Root to Rx, come two free tools for telling what's true. Got Skepticism? runs any claim through a five-move toolkit to test whether your confidence is earned, and Stay in the Room shows you how to disagree without a fight. Both play in your browser in about two minutes at openlabelmedia.com.

New to The Root Room?
The Root Room is our ongoing story. Same characters, same questions, one issue at a time. If this is your first visit, Issues 010, 011, and 012 will catch you up. You can also just start here. It stands on its own, placing you in all the rooms medicine takes from first identification as a treatment target to your medicine cabinet at home.
The Supplement Aisle From Issue 012
The Root Room had been in the Facebook Group “The Root to Rx Lab” for issue 012. Debby had applied the toolkit to a pharma criticism, held both the criticism and the context, and sent a primary source link to her cousin instead of a forwarded post.
This week, she walked into a pharmacy.

The Bag in the Pharmacy
She had ordered it 2 weeks earlier. A bundle of berberine capsules, BPC-157 in a small vial with a research-use label, a greens powder with 47 ingredients listed on the side, and something called “metabolic support formula” whose label listed 12 herbs and 3 percentages of daily values.
She was not sure why she had ordered it. She had been feeling tired. The influencer who recommended it had 2.4 million followers and before-and-after photos and a link in her bio.
She brought the bag to the pharmacy because she was already there to pick up a prescription, and because she had been thinking about Issue 013 before it dropped.

It’s important to bring your medications to your pharmacist to assess interactions. A detailed list of medications and supplements can also help them understand the full picture.
Dr. Lynn, PharmD. The pharmacist had the kind of face that had heard the question before. Not dismissive. Something else. She looked at the bag the way a structural engineer looks at a wall before saying anything.
Dr. Lynn: Can I ask what you’re taking these with?
Debby: Metformin. And an antidepressant, the SSRI.
Dr. Lynn set the bag on the counter and did not open it yet.
Dr. Lynn: Does your prescribing doctor know you’re adding these?
Debby: Not yet. I was going to tell her at my next appointment.
Dr. Lynn: Your next appointment is when?
Debby: 3 months.
Dr. Lynn picked up the berberine.
Dr. Lynn: Berberine has glucose-lowering activity. You’re on metformin. I’m not telling you not to take it. I’m telling you this isn’t a zero-stakes addition to your regimen, and your doctor should know about it before you start, not 3 months from now.
Debby looked at the vial labeled BPC-157.
Dr. Lynn: That one I have less information about, because there’s less information. That’s not a reassuring sentence, I know.

Dr. Anecdote Arrives
He was in the supplement aisle. She noticed him because he was filming.
He was tall, professionally lit by a ring light attached to his phone, and wearing a lab coat with no hospital insignia. He was talking to the camera at a pace that suggested he had said these words before.
Dr. Anecdote: Your body already knows how to heal. The pharmaceutical industry doesn’t want you to know what I’m about to tell you. This compound’s been used in traditional medicine for centuries. My patients have seen incredible results. The studies are out there if you look. Link in bio.
He set a bottle of berberine on the shelf. He picked up a box of something else. He kept filming.
Debby watched him for a moment. Then she turned back to Dr. Lynn.

Dr. Anecdote and his friends rely on fear and hype to drive social media interactions.
Debby: He has 2.4 million followers.
Dr. Lynn: I know. I see what people bring in based on what he posts.
Debby: What do you tell them?
Dr. Lynn: I ask what they’re taking it with. Same question I asked you. Because that’s the question he doesn’t answer.

Debby had the SIGNAL card in her wallet. She had carried it since Issue 007.
She ran “S.”: who’s the source? Dr. Anecdote. Platform: Instagram. Credential: not displayed on the coat. Affiliation: not listed anywhere she could find. Financial relationship: supplement affiliate links in the bio.
She ran “I.”: what is the evidence? He had said “the studies are out there.” She had learned from Issue 003b what to do with that phrase.
She ran “G.”: who else is saying this? She looked up berberine in PubMed. Studies existed. Most were small, short-term, and primarily in non-Western patient populations. The evidence base was not comparable to the metformin trials she had read about in earlier issues.
She didn’t finish the card in the pharmacy. She put the vial of BPC-157 back in the bag and asked Dr. Lynn a question.
Debby: If I was going to take any of this, what would you need me to do first?
Dr. Lynn: Call your doctor today, not in 3 months. Tell her everything in that bag, and even better, write it all down. Let her tell you what the interaction risk is. Then decide.
Debby zipped the bag.
Debby: Okay. I wish I knew how to keep track of all of this.
What She Posted
She posted to the Lab from the parking lot.
Debby: I brought a bag of supplements to the pharmacy today because I’d been reading Issue 013 and I wanted to see what would happen. The pharmacist asked me 3 questions I hadn’t thought about. I’m calling my doctor before I take any of this. The berberine and metformin combo isn’t a zero-stakes thing. I didn’t know that.
Sam the Skeptic: This is the disclosure problem. This is exactly what next issue is about.
Coordinator Nani (via Lab): Thank you for asking. Most people don’t. Let me put something together that’s like what I use when I’m screening a potential clinical trial patient for a study, and I also use it when I’m going for any doctor’s appointment too. It’s especially helpful for ER visits.

Cora, the Heart of the Root Room chimed in on the Facebook group’s thread. “And thank you, Debby, for being open to changing your thoughts on something. It shows a lot of growth.”
Go Deeper This Issue
Wednesday’s Root Room is the story. Thursday’s Plain Talk and The Informed newsletter tracks are the answer keys. Everything Debby and Dr. Lynn ran into gets unpacked in the other two tracks of Issue 013. Plain Talk lands in your inbox this Thursday: what DSHEA actually says, and why a supplement reaches the shelf without the trials a drug has to pass. The Informed goes up the same day for the depth: manufacturing standards, the documented interactions (berberine, St. John’s Wort, red yeast rice), and why the testimonial format is built to sell. If the pharmacy scene raised a question in your head, that is where it gets answered.
Next Week in The Root Room
Coordinator Nani comes to the Lab. She brings 1 document.
It is the form clinical researchers use to track every medication and supplement a trial participant takes. Adapted for patients. And it is live on the Fourthwall shop.
ABOUT OPEN LABEL MEDIA
Root to Rx is part of Open Label Media LLC. Open label is a clinical trial term for a study that hides nothing: no blinding, no hidden group, no sleight of hand. That is the whole point of what we build. Open Label Media exists for evidence literacy, in the open, with no agenda. Root to Rx points that openness at the clinical research world, which is much bigger than the drug companies: the sites, doctors, coordinators, nurses, CROs, scientists, biostatisticians, and regulators who actually run it. You will meet them in the issues ahead.
The views expressed on Root to Rx are my own and do not represent the views or positions of my employer, or any affiliated organization.
Root to Rx | 228 Park Ave S, #29976, New York, New York 10003, United States
You are receiving this because you subscribed at roottorx.com.

